Press Release 02 July 2025 White & Case advises Neopharmed Gentili on acquisition of ORLADEYO®’s European business from BioCryst Pharmaceuticals
Press Release 02 October 2023 White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC
Press Release 11 January 2022 White & Case Advises the Underwriters on Intra-Cellular Therapies, Inc.’s US$460 Million Follow-on Offering
Press Release 29 March 2021 White & Case Advises CM Life Sciences II on Business Combination with SomaLogic